COVID-19: Pfizer requested FDA approval for coronavirus vaccine on Friday – preparations to bring COVID-19 vaccine to US soon, Pfizer seeks FDA clearance

Washington:

Amid the coronavirus outbreak, various countries around the world are developing the COVID-19 vaccine. Many vaccines are in the final stages. Meanwhile, US biotechnology giant Pfizer and its German partner BioNTech on Friday asked the US administration for permission to introduce the vaccine against the Corona virus soon. It is believed to be the first step in the direction of relief following the re-emergence of conditions and the global economic downturn due to the rise of Corona cases in different countries.

Read also

In the era of the Corona virus crisis, the world is looking to scientists to get rid of the global epidemic. The U.S. Food and Drug Administration (FDA) said its vaccines committee will meet on December 10 to review an emergency use authorization application. The head of the organization, Stephen Hahn, said: “The FDA believes that dialogue and transparency are very important in building people’s confidence in the COVID-19 vaccine.”

“I want to assure the American people that the FDA process and data assessment for a potential COVID-19 vaccine will be as open and transparent as possible,” he said. He said he couldn’t guess how long the exam would take. However, the US government says the vaccine could be approved in December.

Recently, pharmaceutical major Pfizer said that in the final analysis, the COVID-19 vaccine was found to be 95% effective and the company said it would seek the necessary approval within a day.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: